Peregrine Capital Management LLC Nevro Corp Transaction History

Peregrine Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 18, 2018	SELL	$44.22 - $75.47 $16.5 Million - $28.1 Million	-372,318 Closed	0 $0
Q2 2018 Jul 12, 2018	BUY	$72.38 - $92.5 $725,175 - $926,757	10,019 Added 2.77%	372,318 $0
Q1 2018 Apr 16, 2018	SELL	$69.46 - $88.57 $4.14 Million - $5.28 Million	-59,597 Reduced 14.13%	362,299 $0
Q4 2017 Jan 24, 2018	BUY	$65.94 - $93.31 $7.81 Million - $11.1 Million	118,436 Added 39.03%	421,896 $0
Q3 2017 Oct 25, 2017	BUY	$80.87 - $91.08 $24.5 Million - $27.6 Million	303,460	303,460 $0

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $140M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Peregrine Capital Management LLC with notifications on news.